Company intelligence / Profile preview

Brookside Research & Development Company

Unknown*, Unknown*, United Stateshighergov.com ↗

Ownership: Private
Development stage: Other

Overview

Brookside Research & Development Company is a private U.S.-based life science company focused on developing innovative behavioral intervention technologies to prevent falls among people with cognitive impairment due to Alzheimer's Disease and related dementias. Their lead program, FallScape for Dementia, uses multimedia tools to train caregivers in daily fall-prevention strategies. The company has received NIH/National Institute on Aging support and is conducting early-phase human studies.

Therapeutic areas: Neurology
Modalities: DeviceBehavioral intervention technology
Industry: Digital Health Medical Devices

Partnerships

National Institute on Aging / NIH grant funding partner/supporter

Beyond the preview

Go deeper on Brookside Research & Development Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brookside Research & Development Company.

Explore the full profile